News Links

Closed-loop in children with type 1 diabetes: Specific challenges. A Stepwise Approach toward Closed-Loop Blood Glucose Control for Intensive Care Unit Patients: Results from a Feasibility Study in Type 1 Diabetic Subjects Using Vascular Micro dialysis with Infrared Spectrometry and a Model Predictive Control Algorithm. Family history of diabetes and distribution of class II HLA genotypes in children with newly diagnosed type 1 diabetes: effect on diabetic ketoacidosis. Early Neural and Vascular Changes in the Adolescent Type 1 and Type 2 Diabetic Retina.

Donor Islet Endothelial Cells in Pancreatic Islet Revascularization. Genetic Analysis of Adult-Onset Autoimmune Diabetes. In August 2011, the Institute of Medicine issued a report on Adverse Effects of Vaccines: Evidence and Causality and concluded that evidence favors rejection of a causal relationship between the MMR and DTaP vaccines and type 1 diabetes. Immunological Applications of Stem Cells in Type 1 Diabetes. The possible role of esRAGE and sRAGE in the natural history of diabetic nephropathy in childhood.

No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). The epidemic of type 1 diabetes: what is it telling us? 2011 Update: antigen-specific therapy in type 1 diabetes. A prevascularized tissue engineering chamber supports growth and function of islets and progenitor cells in diabetic mice. Pervasive Sharing of Genetic Effects in Autoimmune Disease. Free full text available in HTML and PDF formats (PDF link on HTML full text page). High levels of oxidized LDL in circulating immune complexes are associated […]

Reduced Serum Vitamin D-Binding Protein Levels Are Associated With Type 1 Diabetes. Rituximab Selectively Suppresses Specific Islet Antibodies. Differentiation of PDX1 gene-modified human umbilical cord mesenchymal stem cells into insulin-producing cells in vitro. Surface camouflage of pancreatic islets using 6-arm-PEG-catechol in combined therapy with tacrolimus and anti-CD154 monoclonal antibody for xenotransplantation. Incidence rate trends in childhood Type 1 diabetes in Yorkshire, UK 1978-2007: effects of deprivation and age at diagnosis in the south Asian and non-south Asian populations.

Prediction model for the incidence and prevalence of type 1 diabetes in childhood and adolescence: evidence for a cohort-dependent increase within the next two decades in Germany. Pathogenesis of type 1 diabetes: implications for incidence trends. Epidemiology of childhood type 1 diabetes mellitus: lessons from central and eastern European data. Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients.

Pig-to-Nonhuman Primates Pancreatic Islet Xenotransplantation: An Overview. Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link. Therapeutic Impact of Leptin on Diabetes, Diabetic Complications, and Longevity in Insulin-Deficient Diabetic Mice.

Being born in Sweden increases the risk for type 1 diabetes – a study of migration of children to Sweden as a natural experiment. Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same? Increased Numbers of Low-Oxygenated Pancreatic Islets After Intraportal Islet Transplantation.

Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets. See also Researchers identify process that prevents type 1 diabetes from progressing. Development of Autoantibodies in the TrialNet Natural History Study. Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells. Association of Urinary Type IV Collagen With GFR Decline in Young Patients With Type 1 Diabetes. Protection against Autoimmune Diabetes by Silkworm-Produced GFP-Tagged CTB-Insulin Fusion Protein.

Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes. Free full text available in HTML and PDF formats (PDF link within full text article). Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Teplizumab for treatment of type 1 diabetes (Prot�g� study): 1-year results from a randomised, placebo-controlled trial. Predictors of associated autoimmune diseases in families with type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. How viral infections enhance or prevent type 1 diabetes-from mouse to man. C-reactive protein promotes diabetic kidney disease in a mouse model […]

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial. See also ADA: Type 1 Diabetes Vaccine Fails to Show Benefit. Improvements in the Life Expectancy of Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study. See also Life Expectancy Improves for Type 1 Diabetics. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. See also ADA: Biologic Slows Type 1 Diabetes. Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T�Cell Compartment in the 1st Year of Human Type 1 Diabetes. […]